Local pioneers in HIV vaccine studies.
Global partners in the solution.
Experienced Leaders in the Cause
University of Rochester’s HIV Vaccine Clinical Trials Site
We are very proud of the fact that the University of Rochester Medical Center was one of the first research sites in the United States to conduct HIV vaccine studies (beginning in 1988). Due to our long-term experience and expertise, we have been called on to offer guidance and assistance to other HIV studies as well. We currently work with HIV Vaccine Research teams in Sao Paulo, Brazil and Kingston, Jamaica.
Teaming Up to Win
Collaborating with the HIV Vaccine Trials Network (HVTN)
The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists and educators searching for an effective and safe HIV vaccine. The HVTN’s mission is to facilitate the process of testing preventive vaccines against HIV/AIDS.
Our organization conducts all phases of clinical trials, from evaluating experimental vaccines for safety and the ability to stimulate immune responses, to testing vaccine efficacy. The HVTN recognizes the importance of public support in finding a vaccine against AIDS. Our staff and volunteers around the globe work actively to help community members understand the general science of HIV/AIDS vaccines, as well as research methods and clinical trial processes. Through our efforts, we hope to dispel some of the misconceptions that surround HIV/AIDS and human subject studies. Support for the HVTN comes from the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services (DHHS).The Network and NIAID have a close, cooperative working relationship, with shared attention to the intellectual and scientific issues.
The Network’s HIV Vaccine Trial Units are located at leading research institutions in 27 cities on four continents. Internationally renowned HIV vaccine and prevention researchers lead the units. The Network’s headquarters are at the Fred Hutchinson Cancer Research Center in Seattle, Washington.